PortfoliosLab logoPortfoliosLab logo
XLV vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XLV vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in State Street Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XLV achieves a -1.35% return, which is significantly lower than IHE's 9.33% return. Over the past 10 years, XLV has outperformed IHE with an annualized return of 9.48%, while IHE has yielded a comparatively lower 7.97% annualized return.


XLV

1D
3.07%
1M
4.67%
YTD
-1.35%
6M
-0.35%
1Y
16.13%
3Y*
6.92%
5Y*
6.19%
10Y*
9.48%

IHE

1D
2.69%
1M
3.48%
YTD
9.33%
6M
12.42%
1Y
43.59%
3Y*
18.33%
5Y*
10.57%
10Y*
7.97%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XLV vs. IHE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XLV
State Street Health Care Select Sector SPDR ETF
-1.35%14.50%2.47%2.07%-2.08%26.04%13.30%20.45%6.28%21.77%
IHE
iShares U.S. Pharmaceuticals ETF
9.33%31.69%8.13%1.06%-4.87%13.07%13.66%15.47%-7.76%10.64%

Correlation

The correlation between XLV and IHE is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.85

Correlation (3Y)
Calculated over the trailing 3-year period

0.83

Correlation (5Y)
Calculated over the trailing 5-year period

0.84

Correlation (10Y)
Calculated over the trailing 10-year period

0.84

Correlation (All Time)
Calculated using the full available price history since May 8, 2006

0.86

The correlation between XLV and IHE has been stable across timeframes, ranging from 0.83 to 0.86 - a consistent structural relationship.

XLV vs. IHE - Sectors Allocation Comparison


Sectors
XLV
IHE

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XLV
100.0%
IHE
100.0%

Basic Materials

XLV

-

IHE

-

Communication Services

XLV

-

IHE

-

Consumer Cyclical

XLV

-

IHE

-

Consumer Defensive

XLV

-

IHE

-

Energy

XLV

-

IHE

-

Financial Services

XLV

-

IHE

-

Industrials

XLV

-

IHE

-

Real Estate

XLV

-

IHE

-

Technology

XLV

-

IHE

-

Utilities

XLV

-

IHE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XLV vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XLV
XLV Risk / Return Rank: 3131
Overall Rank
XLV Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
XLV Sortino Ratio Rank: 3434
Sortino Ratio Rank
XLV Omega Ratio Rank: 2929
Omega Ratio Rank
XLV Calmar Ratio Rank: 3232
Calmar Ratio Rank
XLV Martin Ratio Rank: 2727
Martin Ratio Rank

IHE
IHE Risk / Return Rank: 8181
Overall Rank
IHE Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 8383
Sortino Ratio Rank
IHE Omega Ratio Rank: 7373
Omega Ratio Rank
IHE Calmar Ratio Rank: 8888
Calmar Ratio Rank
IHE Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XLV vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XLVIHEDifference
Sharpe ratioReturn per unit of total volatility

-1.45

Sortino ratioReturn per unit of downside risk

-1.95

Omega ratioGain probability vs. loss probability

1.19

1.43

-0.24

Calmar ratioReturn relative to maximum drawdown

1.55

5.17

-3.62

Martin ratioReturn relative to average drawdown

3.73

15.58

-11.85

XLV vs. IHE - Sharpe Ratio Comparison

The current XLV Sharpe Ratio is 1.08, which is lower than the IHE Sharpe Ratio of 2.54. The chart below compares the historical Sharpe Ratios of XLV and IHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


XLVIHEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.08

2.54

-1.45

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.42

0.65

-0.23

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.57

0.44

+0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

0.51

-0.05

Drawdowns

XLV vs. IHE - Drawdown Comparison

The maximum XLV drawdown since its inception was -39.17%, roughly equal to the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for XLV and IHE.


Loading charts...

Drawdown Indicators


XLVIHEDifference

Max Drawdown

Largest peak-to-trough decline

-39.17%

-38.20%

-0.97%

Max Drawdown (1Y)

Largest decline over 1 year

-10.47%

-8.47%

-2.00%

Max Drawdown (3Y)

Largest decline over 3 years

-17.11%

-15.92%

-1.19%

Max Drawdown (5Y)

Largest decline over 5 years

-17.11%

-16.03%

-1.08%

Max Drawdown (10Y)

Largest decline over 10 years

-28.40%

-29.59%

+1.19%

Current Drawdown

Current decline from peak

-4.68%

-0.18%

-4.50%

Average Drawdown

Average peak-to-trough decline

-7.12%

-7.92%

+0.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.33%

2.81%

+1.52%

Volatility

XLV vs. IHE - Volatility Comparison

The current volatility for State Street Health Care Select Sector SPDR ETF (XLV) is 5.04%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 6.04%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XLVIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.04%

6.04%

-1.00%

Volatility (6M)

Calculated over the trailing 6-month period

10.67%

12.70%

-2.03%

Volatility (1Y)

Calculated over the trailing 1-year period

14.97%

17.26%

-2.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.76%

16.28%

-1.52%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.57%

18.07%

-1.50%

XLV vs. IHE - Expense Ratio Comparison

XLV has a 0.08% expense ratio, which is lower than IHE's 0.42% expense ratio.


Dividends

XLV vs. IHE - Dividend Comparison

XLV's dividend yield for the trailing twelve months is around 1.65%, more than IHE's 1.61% yield.


PositionTTM20252024202320222021202020192018201720162015
IHE
iShares U.S. Pharmaceuticals ETF
1.61%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%
XLV
State Street Health Care Select Sector SPDR ETF
1.65%1.60%1.67%1.59%1.47%1.33%1.49%2.17%1.57%1.47%1.60%1.43%

Frequently Asked Questions


XLV and IHE have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IHE has higher volatility (6.04%) compared to XLV (5.04%). In terms of maximum drawdown, XLV dropped -39.17% vs IHE's -38.20%.

On 10-year performance, XLV leads with 9.48% vs 7.97% for IHE. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 5.04%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, XLV has performed better with a 9.48% return vs 7.97%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XLV is cheaper with a 0.08% expense ratio, compared with 0.42% for IHE.

XLV has the higher dividend yield at 1.65%, compared with 1.61% for IHE.

XLV tracks Health Care Select Sector Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: State Street and iShares. Their fees differ too: 0.08% for XLV and 0.42% for IHE.

IHE currently has the higher Sharpe Ratio (2.54 vs 1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XLV and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer